Munich’s Temedica adds €25 million in Series B round, now at €42 million
Summary
The extension round was led by existing investors MIG Capital as well as an undisclosed Munich-based family office. Founded in 2016, the digital health startup has previously developed a bundle of apps for the German healthcare market. The offering includes Pelvina, an online course for women to train the pelvic floor; Mineo, for back training; and Waya, an app that aids in weight loss.Now, the company appears to be focused more on the health insights side of things, notably through its platform Permea and associated previously mentioned apps. Offering a holistic understanding of patients care realities.According to the company, from more than 40 billion data points on over 50,000 diagnoses, Temedica cab derive health-related insights on issues such as disease progression, treatment effectiveness, patient journeys, and medication adherence.Temedicas vision is to make a pioneering contribution to the development of personalized medicine by linking health-relevant data to new, evidence-based insights. The newly developed real-world insights platform Permea provides pharmaceutical companies with a deep understanding of patients and their care in the real world, outside of clinical trials.